AbbVie recommends stockholders to reject Shire deal
October 16, 2014 at 00:55 AM EDT
Oct 16 (Reuters) - U.S. pharmaceutical company AbbVie Inc recommended stockholders to vote against its $55 billion takeover of Shire Plc in the wake of a U.S. government move to curb "inversion" deals that allow companies to escape high U.S. taxes by reincorporating abroad.
